Results 171 to 180 of about 46,511 (209)

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Lancet, The, 2020
Kwok-Cheung Lung, Tom Wai-Hin Chung, Hoi-Ping Shum   +2 more
exaly  

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

Clinical Microbiology and Infection, 2021
Nathan Peiffer-Smadja, Antoine Kimmoun, Stéphane Jauréguiberry   +2 more
exaly  

Lopinavir/ritonavir

Reactions Weekly, 2014
  +6 more sources

Lopinavir/ritonavir

Reactions Weekly, 2004
openaire   +2 more sources

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

New England Journal of Medicine, 2020
Bin Cao, Ke Wang, Chaolin Huang
exaly  

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Intensive Care Medicine, 2021
Arabi Y, Lennie P G Derde, Djillali Annane   +2 more
exaly  

Lopinavir/ritonavir

Reactions Weekly, 2015
openaire   +2 more sources

Lopinavir

2010
Harry Lampiris, Mai Vu
openaire   +1 more source

Lopinavir/ritonavir

Reactions Weekly, 2007
openaire   +2 more sources

Lopinavir/ritonavir

Reactions Weekly, 2010
openaire   +2 more sources